The Clinical Development of Thalidomide as an Angiogenesis Inhibitor Therapy for Prostate Cancer

2004 ◽  
Author(s):  
Christopher J. Logothetis
Keyword(s):  
Prostate Cancer ◽  
Angiogenesis Inhibitor ◽  
Clinical Development ◽  
Inhibitor Therapy

Doubling down on tumor suppressor deletion

2020 ◽  
Vol 12 (524) ◽  
pp. eaba2903
Author(s):  
Adam G. Sowalsky
Keyword(s):  
Prostate Cancer ◽  
Tumor Suppressor ◽  
Parp Inhibitor ◽  
Inhibitor Therapy

Codeletion of BRCA2 and RB1 increases prostate cancer sensitivity to PARP inhibitor therapy.

Posttherapeutic Critical Organ Dosimetry of Extensive 177Lu-PSMA Inhibitor Therapy With Metastatic Castration-Resistant Prostate Cancer

2020 ◽  
Vol 45 (4) ◽  
pp. 288-291
Author(s):  
Ahu Özkan ◽  
Burcu Uçar ◽  
Hülya Seymen ◽  
Yasemin Yildiz Yarar ◽  
Fikri Okan Falay ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Inhibitor Therapy ◽  
Castration Resistant Prostate Cancer ◽  
Castration Resistant ◽  
Critical Organ ◽  
Psma Inhibitor
Sign in / Sign up

Export Citation Format

Share Document